FindTrial
Sign In

A Clinical trial to study the effects of a herbal drug Capsule Sailanur Rahim-L' in married women with excessive vaginal discharge (Leucorrhoea).

A Clinical Study on the treatment of excessive vaginal discharge (Leucorrhoea) with Capsule Sailanur Rahim-L

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2009/091/000728
Enrollment
Unknown
Registered
2009-09-22
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Qurs Sailanur Rahim-L: 1000 mg bd for 3 months Control Intervention1: placebo: 1000 mg bd for 3 months

Sponsors

Hamdard National Foundation, Asaf Ali Road , New Dlhi
Lead Sponsor
Jamia Hamdard, Hamdard Nagar, New Delhi
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Married women belonging to 20-40 Years of age, having leucorrhoea due to:- ?Non- infective cervical lesions eg. Cervical erosion (ectropion), chronic cervicitis, and mucous polyps. ?Increased pelvic congestion eg. Uterine Prolapse, acquired retroverted uterus, chronic pelvic inflammation.

Exclusion criteria

Exclusion criteria: 1.Pregnancy or lactation 2.Patients taking any oral contraceptive pills 3.Patients with any intrauterine contraceptive device-(IUCD) 4.Physiological leucorrhoea (around ovulation, premenstrual, pregnancy) 5.Abnormal (excessive) vaginal discharge due to:- a)Specific or non specific infection b)Neoplasm c)Foreign body

Design outcomes

Primary

MeasureTime frame
Improvement in LeucorrhoeaTimepoint: 4,6,8,12 weeks—

Secondary

MeasureTime frame
Improvement in the etiological factors responsible for leucorrhoeaTimepoint: 3 months—

Countries

India

Contacts

Public ContactTabiba Yasmeen Shamsi
info.ijum@gmail.com01126059692

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026